OLEMA PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-8.4M | $3.1M |
| FY2019 | — | $-10.6M | $68.0K |
| FY2020 | — | $338.1M | $338.5M |
| FY2021 | — | $284.6M | $13.8M |
| FY2022 | — | $197.5M | $23.7M |
| FY2023 | — | $253.9M | $68.5M |
| FY2024 | — | $409.0M | $139.5M |
| FY2025 | — | $478.6M | $48.3M |